Filings

8 documents · 16 matches

1. HALO HALOZYME THERAPEUTICS, INC. 10-K 2026-02-17

   Item 1A. Risk Factors

   tariffs by the U.S. to accomplish certain policy goals. Such tariffs and any countermeasures by the U.S.’ trading partners could
   4 matches in this document Show context Copy citation

2. HALO HALOZYME THERAPEUTICS, INC. 10-Q 2025-11-03

   Item 1A. Risk Factors

   tariffs by the U.S. to accomplish certain policy goals. Such tariffs and any countermeasures by the U.S.’ trading partners could
   3 matches in this document Show context Copy citation

3. HALO HALOZYME THERAPEUTICS, INC. 10-Q 2025-08-05

   Item 1A. Risk Factors

   tariffs by the U.S. to accomplish certain policy goals. Such tariffs and any countermeasures by the U.S.’ trading partners could
   3 matches in this document Show context Copy citation

4. HALO HALOZYME THERAPEUTICS, INC. 10-Q 2026-11-05

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   tariffs, trade and pharmaceutical pricing policies, tax legislation, timing and success of the launch of new products by us and our partners
   1 match in this document Show context Copy citation

5. HALO HALOZYME THERAPEUTICS, INC. 10-Q 2026-08-06

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   tariffs, trade and pharmaceutical pricing policies, tax legislation, timing and success of the launch of new products by us and our partners
   1 match in this document Show context Copy citation

6. HALO HALOZYME THERAPEUTICS, INC. 10-Q 2026-05-11

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   tariffs, trade and pharmaceutical pricing policies, tax legislation, timing and success of the launch of new products by us and our partners
   1 match in this document Show context Copy citation

7. HALO HALOZYME THERAPEUTICS, INC. 8-K 2025-11-03

   related to tariff, trade and pharmaceutical pricing policies and tax legislation, unexpected adverse events or patient outcomes and competitive conditions.
   1 match in this document Show context Copy citation

8. HALO HALOZYME THERAPEUTICS, INC. 8-K 2025-08-05

   The Company is raising its financial guidance for 2025. Note that the guidance reflects tariffs that are currently implemented.
   2 matches in this document Show context Copy citation